Management Team

Laura A. Francis has served as our Chief Executive Officer and a Director on our Board since April 2021.  As our Chief Financial Officer since May 2015 and Chief Operating Officer since July 2019, Ms. Francis played a fundamental role in bringing the company public in October 2018 and building the

Anthony J. Recupero was named President, Commercial Operations by SI-BONE in April 2021. In this role, Mr. Recupero leads all aspects of SI-BONE’s commercial operations, including sales, marketing, reimbursement, medical affairs and international markets. A proven commercial leader, Mr.

Anshul Maheshwari joins SI-BONE with over 15 years of experience in corporate finance, banking, treasury, and strategy. Most recently, Mr. Maheshwari served as Vice President of Finance, Investor Relations and Treasurer for Varian Medical Systems, a leading cancer care platform, where he held roles

Michael A. Pisetsky was named Chief Business & Legal Affairs Officer in April 2023. In this role, Mr. Pisetsky leads all aspects of SI-BONE’s supply chain and customer service operations, as well as its Legal, Quality Assurance, Program Management, IT and other administrative support organizations,

W. Carlton Reckling, MD has served as our Vice President, Medical Affairs since April 2012 and our Chief Medical Officer since February 2017. From July 1994 to April 2012, Dr. Reckling was a spine surgeon at the Spine Center in Loveland, Colorado, Rocky Mountain Orthopedic Specialists in Cheyenne,

Scott A. Yerby, PhD was named Senior Vice President of Engineering & Chief Technology Officer by SI-BONE in April 2021.  In this role, Dr. Yerby is responsible for developing and bringing to market innovative solutions that help treat sacropelvic conditions. Prior to SI-BONE, Dr.

Daniel J. Cher, MD was named Senior Vice President of Clinical and Regulatory Affairs in June 2021. Dr. Cher has served as our Vice President, Clinical Affairs since January 2012. From May 2008 to December 2011, Dr. Cher served as Vice President of Clinical and Regulatory Affairs at Chestnut

Nikolas F. Kerr has served as our Vice President, Product Management since August 2016. Prior to joining us, Mr. Kerr was President of Kerr Consulting Group where he advised leading medical device companies on product strategy. Previously, Mr. Kerr was Senior Director of Marketing for Benvenue

Troy S. Wahlenmaier has served as our Vice President of U.S. Sales since January 2018.  Mr. Wahlenmaier joined us in February 2012, serving in sales management positions and earning promotions to Western Area Director of Sales in July 2014 and Senior Director of National Sales in July 2016.  Mr.

Robyn Capobianco, PhD joins SI-BONE as Vice President of Clinical Affairs. She brings 20 years of spine medical device experience across functions including professional education, sales, clinical marketing, and clinical affairs. Most recently Dr. Capobianco was the Global Clinical Program Director

Sarah Duranske was named Vice President, Legal of SI-BONE in January 2022.  Ms. Duranske is a seasoned business lawyer with experience in the life sciences and technology industries. She has cross-functional expertise in corporate, commercial, employment, compliance, clinical, and marketing

Ms. Einstein has held key leadership positions in the medical device and biotech industries, including Johnson & Johnson and most recently Genentech/Roche.  She brings over 15 years of experience in a diversity of disciplines including learning and organizational development, people and culture,

Joyce Goto brings over 20 years of financial management and accounting experience to SI-BONE. Prior to joining SI-BONE, Ms. Goto was the chief accounting officer at BioPharmX, a public, specialty pharmaceutical company focused on dermatology indications, until its acquisition by Timber

Neville Lorimer joined SI-BONE in September 2022 as Vice President, International with responsibility for EMEA, Japan and Rest of World (ROW). Mr. Lorimer is a seasoned Sales and Marketing executive with over 21 years in the healthcare industry. Prior to joining SI-BONE, Mr.

Mr. Maw joined SI-BONE in 2014 and has nearly 30 years of experience in health care sales, sales management, marketing and national accounts experience. The majority of his career has been spent working within young growth organizations that focus on building markets via transformational,

Roxanne Simon was named Vice President of Program Management and Quality & Process Improvement by SI-BONE in October 2021. In this role, Ms. Simon is responsible for overseeing the Quality Assurance team and implementation and management of SI-BONE’s Quality Management System, overseeing the

Jeffrey D. Zigler has served as our Vice President, Market Access and Reimbursement since January 2019. Prior to joining us, Mr. Zigler led the Reimbursement and Health Economics team at LDR Spine, until its acquisition in 2016 by Zimmer Biomet, a global orthopedics technology company, where he